InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Pascal Deschatelets, Chief Scientific Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 33 open-market SEC Form 4 transactions: 0 purchases worth $0 and 33 sales worth $22.0M, reported from Apr 29, 22 to Jan 22, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 22, 26 | APLSApellis Pharmaceuticals, Inc. | SELL | 5.9K | $21.77 | $129K |
| Jan 20, 26 | APLSApellis Pharmaceuticals, Inc. | SELL | 909 | $19.79 | $18K |
| Jan 13, 26 | APLSApellis Pharmaceuticals, Inc. | SELL | 2.3K | $22.19 | $51K |
| Jan 29, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 826 | $29.52 | $24K |
| Jan 22, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 3.9K | $30.43 | $120K |
| Jan 17, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 750 | $29.96 | $22K |
| Jan 13, 25 | APLSApellis Pharmaceuticals, Inc. | SELL | 2.3K | $28.70 | $66K |
| May 8, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 56.3K | $44.03 | $2.4M |
| Apr 8, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 64.4K | $54.92 | $3.5M |
| Mar 8, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 42.8K | $63.35 | $2.6M |
| Feb 12, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 1.1K | $67.77 | $78K |
| Jan 29, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 874 | $64.14 | $56K |
| Jan 22, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 3.9K | $65.00 | $254K |
| Jan 16, 24 | APLSApellis Pharmaceuticals, Inc. | SELL | 1.6K | $66.81 | $109K |
| Nov 8, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $47.27 | $567K |
| Oct 9, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $40.38 | $485K |
| Sep 8, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $42.87 | $514K |
| Aug 8, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $23.66 | $284K |
| Jul 10, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $84.55 | $1.0M |
| Jun 8, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $91.35 | $1.1M |
| May 8, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $92.39 | $1.1M |
| Apr 10, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $78.21 | $939K |
| Mar 8, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $63.79 | $765K |
| Feb 8, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $54.45 | $653K |
| Jan 9, 23 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $46.08 | $553K |
| Dec 8, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $47.50 | $570K |
| Nov 8, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $46.47 | $558K |
| Oct 10, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $57.50 | $690K |
| Sep 8, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $63.98 | $768K |
| Aug 8, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $62.50 | $750K |
| Jul 8, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $47.95 | $575K |
| Jun 8, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 12.0K | $44.09 | $529K |
| Apr 29, 22 | APLSApellis Pharmaceuticals, Inc. | SELL | 4.0K | $44.43 | $178K |